Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report

Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Bela J, Mistry, Deval, Chaudhary, Navin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537689/
https://www.ncbi.nlm.nih.gov/pubmed/31148866
http://dx.doi.org/10.4103/ijd.IJD_633_18
_version_ 1783422066604638208
author Shah, Bela J
Mistry, Deval
Chaudhary, Navin
author_facet Shah, Bela J
Mistry, Deval
Chaudhary, Navin
author_sort Shah, Bela J
collection PubMed
description Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until now, there have been no documented case of apremilast therapy for HIV-associated psoriasis in India. Here, we report a case of HIV-associated psoriasis who achieved Psoriasis Area and Severity Index (PASI) 100 with apremilast therapy.
format Online
Article
Text
id pubmed-6537689
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-65376892019-05-30 Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report Shah, Bela J Mistry, Deval Chaudhary, Navin Indian J Dermatol Case Report Psoriasis is a chronic papulosquamous skin disease that involves immune-mediated cutaneous inflammation and keratinocyte hyperproliferation. The associated immunosuppression in people living with HIV (PLHIV) with psoriasis poses a challenge to the clinician as therapeutic options are limited. Until now, there have been no documented case of apremilast therapy for HIV-associated psoriasis in India. Here, we report a case of HIV-associated psoriasis who achieved Psoriasis Area and Severity Index (PASI) 100 with apremilast therapy. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6537689/ /pubmed/31148866 http://dx.doi.org/10.4103/ijd.IJD_633_18 Text en Copyright: © 2019 Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Shah, Bela J
Mistry, Deval
Chaudhary, Navin
Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title_full Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title_fullStr Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title_full_unstemmed Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title_short Apremilast in People Living with HIV with Psoriasis Vulgaris: A Case Report
title_sort apremilast in people living with hiv with psoriasis vulgaris: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537689/
https://www.ncbi.nlm.nih.gov/pubmed/31148866
http://dx.doi.org/10.4103/ijd.IJD_633_18
work_keys_str_mv AT shahbelaj apremilastinpeoplelivingwithhivwithpsoriasisvulgarisacasereport
AT mistrydeval apremilastinpeoplelivingwithhivwithpsoriasisvulgarisacasereport
AT chaudharynavin apremilastinpeoplelivingwithhivwithpsoriasisvulgarisacasereport

Ejemplares similares